Documentos de Académico
Documentos de Profesional
Documentos de Cultura
¿Por qué nos vamos a centrar en Esquizofrenia y Enfermedad de Alzheimer (EA)? (Dubrakva et al., 2016)
Objetivo Revisión:
Figura 3: Representación
hipótesis 3 vías.
Adaptado de De
Mqueigar -CC BY-SA 3.0.
Figura 2: Teoría serotoninérgica. Recuperado de Stahl, 2018
Sistema Serotoninérgico y Cognición
En Esquizofrenia: En EA:
En Esquizofrenia:
En EA:
En Esquizofrenia:
En Esquizofrenia:
En EA:
En EA:
Beliveau, V., Ganz, M., Feng, L., Ozenne, B., Højgaard, L., Fisher, P. M., Svarer, C., Greve, D. N., & Knudsen, G. M.
(2017). A High-Resolution In Vivo Atlas of the Human Brain’s Serotonin System. The Journal of Neuroscience,
37(1), 120–128. https://doi.org/10.1523/jneurosci.2830-16.2017
García-Bea, A., Miranda-Azpiazu, P., Muguruza, C., Marmolejo-Martinez-Artesero, S., Diez-Alarcia, R., Gabilondo,
A. M., Callado, L. F., Morentin, B., González-Maeso, J., & Meana, J. J. (2019). Serotonin 5-HT2A receptor
expression and functionality in postmortem frontal cortex of subjects with schizophrenia: Selective biased
agonism via Gαi1-proteins. European Neuropsychopharmacology, 29(12), 1453–1463.
https://doi.org/10.1016/j.euroneuro.2019.10.013
Hurlemann, R., Matusch, A., Kuhn, K. U., Berning, J., Elmenhorst, D., Winz, O., Kolsch, H., Zilles, K., Wagner, M.,
Maier, W., & Bauer, A. (2007). 5-HT2A receptor density is decreased in the at-risk mental state.
Psychopharmacology, 195(4), 579–590. https://doi.org/10.1007/s00213-007-0921
Kandel, E. R., Schwartz, J. H., Jessell, T. M., Siegelbaum, S. A., Hudspeth, A. J., & Hudspeth, A. J. (2012). Principles
of Neural Science, Fifth Edition (Principles of Neural Science (Kandel)) (English Edition) (5.a ed.). McGraw-Hill
Education / Medical.
Referencias
Knudsen, G. M., Jensen, P. S., Erritzoe, D., Baaré, W. F., Ettrup, A., Fisher, P. M., Gillings, N., Hansen, H. D., Hansen,
L. K., Hasselbalch, S. G., Henningsson, S., Herth, M. M., Holst, K. K., Iversen, P., Kessing, L. V., Macoveanu, J.,
Madsen, K. S., Mortensen, E. L., Nielsen, F. R., . . . Frokjaer, V. G. (2016). The Center for Integrated Molecular
Brain Imaging (Cimbi) database. NeuroImage, 124, 1213–1219.
https://doi.org/10.1016/j.neuroimage.2015.04.025
Purves, F. R. I. N. D., Augustine, G. J., Fitzpatrick, D., Hall, W. C., Lamantia, A., Mooney, R. D., Platt, M. L., & White,
L. E. (2017). Neuroscience (6th ed.). Sinauer Associates Is an Imprint of Oxford University Press.
Saulin, A., Savli, M., & Lanzenberger, R. (2011). Serotonin and molecular neuroimaging in humans using PET.
Amino Acids, 42(6), 2039–2057. https://doi.org/10.1007/s00726-011-1078-9
Sgambato-Faure, V., Billard, T., Météreau, E., Duperrier, S., Fieux, S., Costes, N., Tremblay, L., & Zimmer, L. (2017).
Characterization and Reliability of [18F]2FNQ1P in Cynomolgus Monkeys as a PET Radiotracer for Serotonin
5-HT6 Receptors. Frontiers in Pharmacology, 8, 1. https://doi.org/10.3389/fphar.2017.00471
Referencias
Šimić, G., Babić Leko, M., Wray, S., Harrington, C. R., Delalle, I., Jovanov-Milošević, N., Bažadona, D., Buée, L., de
Silva, R., Di Giovanni, G., Wischik, C. M., & Hof, P. R. (2017). Monoaminergic neuropathology in Alzheimer's
disease. Progress in neurobiology, 151, 101–138. https://doi.org/10.1016/j.pneurobio.2016.04.001
Stahl, S. (2018). Beyond the dopamine hypothesis of schizophrenia to three neural networks of psychosis:
Dopamine, serotonin, and glutamate. CNS Spectrums, 23(3), 187-191. doi:10.1017/S1092852918001013
Stahl, S. M., & Muntner, N. (2013). Stahl’s Essential Psychopharmacology: Neuroscientific Basis and Practical
Applications (4th Revised ed.). Cambridge University Press.
Švob Štrac, D., Pivac, N., & Mück-Šeler, D. (2016). The serotonergic system and cognitive function. Translational
neuroscience, 7(1), 35–49. https://doi.org/10.1515/tnsci-2016-0007